drotrecogin alfa
drotrecogin alfa.JPG

drotrecogin alfa

CLINICAL USE

Treatment of adult patients with severe sepsis with multiple organ failure

DOSE IN NORMAL RENAL FUNCTION

24 micrograms/kg/hour for 96 hours

PHARMACOKINETICS

  • Molecular weight                           :Approx 55 000
  • %Protein binding                           :No data
  • %Excreted unchanged in urine     : No data
  • Volume of distribution (L/kg)       :8.2–31.2 litres
  • half-life – normal/ESRD (hrs)      :13 minutes/–

    DOSE IN RENAL IMPAIRMENT

    GFR (mL/MIN)

  • 20 to 50     : Dose as in normal renal function
  • 10 to 20     : Dose as in normal renal function
  • <10           : Dose as in normal renal function

    DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

  • CAPD                :Unlikely to be dialysed. Dose as in normal renal function
  • HD                     :Unlikely to be dialysed. Dose as in normal renal function
  • HDF/high flux   :Unlikely to be dialysed. Dose as in normal renal function
  • CAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function

    IMPORTANT DRUG INTERACTIONS

    Potentially hazardous interactions with other drugs
  • Heparin: avoid concomitant use with high dose heparin
  • Thrombolytic therapy: avoid for 3 days before administering drotrecoginOral anticoagulants, antiplatelets: avoid for 7 days before administering drotrecogin

    ADMINISTRATION

    Reconstition

    Water for injection

    Route

    IV infusion

    Rate of Administration

    24 micrograms/kg/hour

    Comments

    Further dilute with sodium chloride 0.9% to a concentration of 100–200 mcg/mLMinimum volume: 20 mg in 50 mL. (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006)

    OTHER INFORMATION

    No anticoagulation is required for haemofiltration as the drotrecogin acts as an anticoagulantCan be started 12 hours after major invasive procedures or surgeryClearance is reduced by 30% in renal impairment but no dose reduction is required Has a short half-life of 13 minutes and a β-half-life of 1.6 hours
  • Plasma clearance: Patients with sepsis: 41.8 L/hour —Healthy subjects: 28.1 L/hour —Haemodialysis patents: 30 L/hour —Peritoneal dialysis patients: 23 L/hour



    See how to identify renal failure stages according to GFR calculation

    See how to diagnose irreversible renal disease

    Home

  • other drugs